INTS vs LCID
Intensity Therapeutics, Inc. Common stock (INTS) versus Lucid Group Inc (LCID) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Lucid Group Inc (LCID) is a auto manufacturers company listed on NASDAQ. It is led by Peter Rawlinson.
INTS does not have a complete income-statement cache yet.
Latest reported LCID revenue for 2025-12-31 was $1.35B. Net income was -$2.70B. Revenue was up 67.6% from 2024-12-31 to 2025-12-31. LCID currently screens at market cap $2.04B.
INTS currently screens at market cap $7.7M. LCID currently screens at market cap $2.04B.
Not investment advice. Open the INTS and LCID stock pages for the full models.
Not investment advice.